Clinical Trial Update: Clinical Pharmacology Study of CHF1535 pMDI 50/6 µg Versus The Free Combination In Asthmatic Children 5-11 Years Old [Phase 2]

View source ↗

Summary

Phase 2 clinical pharmacology study comparing CHF1535 pMDI 50/6 µg to the free combination in asthmatic children aged 5-11 years has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CHF1535 pMDI 50/6 µg

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 2 | Status: COMPLETED